首页> 外文期刊>Human Pathology >Micropapillary early gastric carcinoma with distinct clinicopathological features, high risk for lymph node metastasis, and dismal prognosis: a multicenter clinicopathological study of 29 cases identified in 1890 early gastric carcinoma radical gastrectomies
【24h】

Micropapillary early gastric carcinoma with distinct clinicopathological features, high risk for lymph node metastasis, and dismal prognosis: a multicenter clinicopathological study of 29 cases identified in 1890 early gastric carcinoma radical gastrectomies

机译:微杂皮病早期胃癌具有明显的临床病理特征,淋巴结转移的高风险,令人沮丧的预后:1890年早期胃癌自由基胃切除术中鉴定了29例的多中心临床病理学研究

获取原文
获取原文并翻译 | 示例
       

摘要

Clinicopathology and risk factors of lymph node metastasis (LNM) in micropapillary early (pT1) gastric carcinoma (MEGC) remain elusive because of the extreme rarity. In this multicenter study, we investigated 1890 consecutive radical resections of early gastric carcinoma diagnosed with the World Health Organization criteria and identified 29 (1.5%) MEGC cases with a small (= 5%) micropapillary component. MEGC showed a male predominance (male-to-female ratio, 21:8). Most (93.1%; 27/29) tumors invaded submucosa. Lymphovascular invasion was detected in 14 (48.3%) of 29 cases. LNM was found in 13 cases (44.8%; 11 identified with a routine hematoxylin-eosin stain and 2 additional cases with a positive pancytokeratin immunostain). Overall, independent risk factors for LNM in early gastric carcinoma included patient age of 62 years or less, female sex, noncardiac location, ulcerative pattern, tumor size of greater than 2 cm, submucosal invasion, Lauren diffuse type, lymphovascular invasion, and MEGC. In MEGC, advanced pathologic stages were demonstrated in 6 (20.7%) of 29 cases. The 5-year overall survival rate of MEGC patients was 58.6%. Submucosal invasion, lymphovascular invasion, and LNM were significantly more frequent in the MEGC group than in the non-MEGC groups. Advanced pathologic stages were significantly more common in MEGC than in nonmicropapillary Lauren intestinal-but not diffuse-type early gastric carcinomas. In conclusion, MEGC demonstrated a high propensity for lymphovascular invasion, LNM with advanced stages, and dismal prognosis. (C) 2018 Elsevier Inc. All rights reserved.
机译:由于极端罕见,微胃癌早期(PT1)胃癌(PT1)胃癌(PT1)胃癌(PT1)胃癌(MEGC)的临床病理学和危险因素仍然难以实现。在该多中心研究中,我们调查了1890年,连续的自然切除早期胃癌,诊断出世界卫生组织标准,并确定了29例(1.5%)兆颈病例,小(& = 5%)微杂种组分。 MEGC展示了男性优势(男性与女性比例,21:8)。大多数(93.1%; 27/29)肿瘤侵入粘膜。在29例中检测到淋巴血管侵袭。在13例中发现LNM(44.8%; 11用常规血清毒素染色染色,2例含有阳性胰岛素蛋白免疫蛋白免疫蛋白的另外案例)。总体而言,早期胃癌中LNM的独立危险因素包括患者年龄62岁或更短,女性,非心动性位置,溃疡性,肿瘤大小大于2厘米,粘膜侵袭,劳伦弥漫性型,淋巴血管入侵和MEGC。在MEGC中,先进的病理阶段在6例(20.7%)的29例中证实。百分比患者的5年总生存率为58.6%。粘膜侵袭,淋巴血管侵袭和LNM在兆群中显着频繁,而不是非兆年组。高级病理阶段在MEGC中显着更常见于非二甲酰劳伦肠 - 但不是弥漫式早期胃癌。总之,MEGC展示了淋巴血管侵袭,LNM具有高级阶段的高度倾向,令人沮丧的预后。 (c)2018年Elsevier Inc.保留所有权利。

著录项

  • 来源
    《Human Pathology》 |2019年第2019期|共10页
  • 作者单位

    Nanjing Med Univ Dept Pathol Affiliated Changzhou Peoples Hosp 2 Changzhou 213003 Peoples R;

    Soochow Univ Dept Pathol Hosp 1 Suzhou 215006 Peoples R China;

    Jiangsu Prov Hosp Tradit Chinese Med Dept Pathol Nanjing 210029 Jiangsu Peoples R China;

    Nanjing Univ Dept Pathol Affiliated Nanjing Drum Tower Hosp Sch Med Nanjing 210008 Peoples R;

    Nanjing Med Univ Dept Pathol Affiliated Changzhou Peoples Hosp 2 Changzhou 213003 Peoples R;

    Nanjing Univ Dept Pathol Affiliated Nanjing Drum Tower Hosp Sch Med Nanjing 210008 Peoples R;

    Nanjing Univ Dept Pathol Affiliated Nanjing Drum Tower Hosp Sch Med Nanjing 210008 Peoples R;

    Soochow Univ Dept Pathol Hosp 1 Suzhou 215006 Peoples R China;

    Jiangsu Prov Hosp Tradit Chinese Med Dept Pathol Nanjing 210029 Jiangsu Peoples R China;

    Nanjing Med Univ Dept Pathol Affiliated Changzhou Peoples Hosp 2 Changzhou 213003 Peoples R;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    Stomach; Carcinoma; Early gastric carcinoma; Micropapillary carcinoma; Lymph node; Metastasis;

    机译:胃;癌;早期胃癌;微杂种癌;淋巴结;转移;
  • 入库时间 2022-08-20 08:10:55

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号